Male Syrian hamsters (Mesocricetus auratus) treated with anabolic/androgenic steroids (AAS) during adolescence (P27-P56) display highly escalated and mature forms of offensive aggression correlated with increased γ-aminobutyric acid (GABA) afferent development as well as decreased GABA A receptors in the lateroanterior hypothalamus (LAH)an area of convergence for developmental and neuroplastic changes that underlie offensive aggressive behaviors in hamsters. This study investigated whether microinfusion of a GABA A receptor agonist (muscimol; 0.01-1.0 pmol/l) or antagonist (bicuculline; 0.04-4.0 pmol/l) directly into the LAH modulate adolescent AAS-induced offensive aggression. Activation of LAH GABA A receptors enhanced adolescent AAS-induced offensive aggression, beginning at the 0.1 pmol/l dose, when compared with AAS-treated animals injected with saline into the LAH. Importantly, GABA A receptor agonism within the LAH significantly increased the frequency of belly/rear attacks, while simultaneously decreasing the frequency of frontal attacks. These data identify a neuroanatomical locus where GABA A receptor activation functions to enhance aggression in adolescent AAS-treated animals, while also promoting the display of mature forms of aggression and suppressing juvenile play behaviors. Behavioural Pharmacology 25:673-683
Introduction
For over a decade we have used pubertal male Syrian hamsters (Mesocricetus auratus) as an adolescent animal model to investigate the effects of adolescent anabolic/ androgenic steroids (AAS) exposure on the behavioral neurobiology of offensive aggression [Harrison et al., 2000a; DeLeon et al., 2002; Ricci et al., 2004 Ricci et al., , 2007 Jackson et al., 2005; Knyshevski et al., 2005a Knyshevski et al., , 2005b  see Melloni and Ricci (2010) for a review]. Behavioral data from these studies show that adolescent hamsters repeatedly exposed to moderate doses of AAS (5.0 mg/kg/day) display a mature and significantly escalated aggressive phenotype in the absence of prior social interactions and established dominance cues, suggesting that this treatment regimen impacts the temporal development of aggression and the select brain systems implicated in the complex control of this behavior. Neurobiological data from these studies identify the anterior hypothalamus (AH) as a point of convergence for developmental and neuroplastic changes that align with the mature and highly aggressive phenotype. In hamsters, the AH exists at the center of a neural network of reciprocal connections between the bed nucleus of the stria terminalis, lateral septum, medial amygdala, and ventrolateral hypothalamus that regulate offensive aggression (Delville et al., 2000) . Recently we showed that adolescent hamsters stimulated to respond aggressively following AAS administration display significant alterations in the development and function of several neurotransmitter systems implicated in the control of aggressive behavior, that is, the vasopressin (AVP) (Harrison et al., 2000b; Grimes et al., , 2007 Melloni and Ricci, 2010; Carrillo et al., 2011) , serotonin (5HT) Melloni, 2002, 2005; Ricci et al., 2006) and dopamine (DA) neural systems Schwartzer et al., 2009; Melloni and Ricci, 2010; Melloni, 2010a, 2010b) . Notably, these alterations were each observed in a ventrolateral subregion of the AH designated the lateroanterior hypothalamus (LAH) (Harrison et al., 2000b; DeLeon et al., 2002; Grimes and Melloni, 2005; Ricci et al., 2006) . Behavioral pharmacology studies employing receptor agonists and antagonists for the AVP, 5HT, and DA neural systems show that increased aggressive behavior in adolescent AAS-treated hamsters is modulated directly by the activity of these systems within the LAH (Harrison et al., 2000b; Melloni, 2010a, 2010b; Carrillo et al., 2011) . Together, these data suggest that the LAH is an important point of convergence for neurodevelopmental and neuroplastic changes underlying adolescent AAS-induced offensive aggression, supporting the notion that the aggression-stimulating properties of adolescent AAS exposure are modulated by LAH neural signaling through select neurochemical systems.
The neurotransmitter γ-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system. Similar to AVP, 5HT, and DA, GABA has been implicated in aggressive behavior in various species and behavioral models, yet its role appears complex, both suppressing (Earley and Leonard, 1977; Krsiak et al., 1981; Poshivalov, 1981; Puglisi-Allegra et al., 1981; Potegal et al., 1982; Haug et al., 1984; Clement et al., 1987; Chapouthier, 1996, 1998) and facilitating (Christmas and Maxwell, 1970; Cole and Wolf, 1970; DiMascio, 1973; Depaulis and Vergnes, 1985; Rodgers and Waters, 1985; Weerts et al., 1993; Stork et al., 2000) aggression. Across the neuraxis, GABA has been localized to both neurons and axon terminals Feldblum et al., 1993; Fenelon et al., 1995; Bowers et al., 1998; Chen et al., 1998; Sur et al., 1999) , including those that comprise the reciprocal hypothalamic neural circuit regulating aggressive behavior in hamsters; in particular the AH and LAH (Grimes et al., 2003; Schwartzer et al., 2009 ). In the central nervous system, GABA has been shown to exert its inhibitory action mainly through postsynaptic GABA A receptors, and aggressive behavior has been shown to be mediated by alterations in GABA A receptor activity (Jorge et al., 2002; Miczek et al., 2003; De Almeida et al., 2005) . Recently, we localized a dense concentration of GABA A receptors aligned across the LAH , so it is possible that GABA activity alters the activity of LAH GABA A receptor-containing neurons that normally function to modulate aggression.
Previously, we showed that adolescent AAS exposure increases GABA-containing afferent terminals across the AH in hamsters (Grimes et al., 2003) , suggesting that AH GABA activity is increased in aggressive, adolescent AAS-treated animals. This increase was not localized specifically to the LAH as we observed previously with AVP, 5HT, and DA afferents, suggesting that AH GABA neurons provide a diffuse inhibitory influence over neurons throughout the AH, and that this inhibitory influence is increased by adolescent AAS exposure. Conversely, an increase in GABA-containing neuronal somata were found exclusively within the LAH brain region after AAS exposure ), suggesting that the source of increased GABA afferents within the AH originate from GABA neurons in this brain region, and that adolescent AAS-induced increases in LAH GABA activity contribute to the mature and highly escalated adolescent AAS-induced aggressive phenotype. In contrast, while adolescent AAS exposure increases GABA production within the LAH and afferent development across the AH, subsequent studies from our laboratory have shown that aggressive, adolescent AAS-treated hamsters have fewer GABA Aα1 subunitcontaining receptors in the LAH , bringing into question whether the development of the mature, highly aggressive phenotype in AAS-treated animals is because of an increase in the overall activity of GABA within the LAH. To examine this question, animals were treated with AAS throughout adolescent development and tested for aggressive behavior following direct pharmacological manipulations of LAH GABA signaling to determine whether alterations in GABA signaling through GABA A receptors in the LAH modulate adolescent AAS-induced offensive aggression.
Methods

Subjects
Male Syrian hamsters (M. auratus) (N = 105) were obtained from Charles River Laboratories (Wilmington, Massachusetts, USA) individually housed in polycarbonate cages, and maintained at ambient room temperature (22-24°C, with 55% relative humidity) on a reverse light-dark cycle (14 L:10 D; lights off at 08:00 h) as previously described . Food and water were freely available. For aggression testing, stimulus (intruder) males of equal size and weight to the experimental animals were obtained from Charles River Laboratories 1 week before the behavioral test, group-housed (five animals per cage) in large polycarbonate cages, and maintained as above to acclimate to the animal facility. All studies employing live animals were preapproved by the Northeastern University Institutional Animal Care and Use Committee and all methods used were consistent with guidelines provided by the National Institutes of Health for the scientific treatment of animals.
Experimental treatment
On postnatal day (P) 27 hamsters (n = 90) received daily subcutaneous injections (0.1-0.2 ml) of an AAS mixture consisting of 2 mg/kg testosterone cypionate, 2 mg/kg nandrolone decanoate, and 1 mg/kg boldenone undecylenate dissolved in sesame oil, for 30 consecutive days during adolescent development (P27-P56). As a control, a separate set of animals received subcutaneous injections of an equivalent volume of sesame oil (vehicle) alone (n = 15). This treatment regimen, designed to mimic a chronic AAS use regimen Katz, 1988, 1994) , has been shown repeatedly to produce highly aggressive animals in greater than 90% of the AAS treatment pool (Ricci et al., 2013) .
Surgical procedure
One week before aggression testing (P50), animals (N = 105) were anesthetized with isoflurane (1-4%, inhalation) and placed into a stereotaxic device for unilateral implantation of a 26-G guide cannula aimed at the LAH. An incision was made to expose the dorsal surface of the skull to reveal the position of lambda and bregma landmarks. A small hole was drilled into the skull at the coordinate position necessary to gain access to the LAH, that is, 0.7 mm posterior to bregma, 0.6 mm lateral to the midsagittal suture, 6.8 mm ventral from dura.
The cannula was placed in the brain angled at 8°and anchored to the skull using dental screws and acrylic and head-wound then sutured closed.
Microinjections
A 2-μl Hamilton syringe was connected to a 33-G stainless injection needle using polyethylene tubing. Injection of drugs into the LAH was performed by lowering the injection needle through the guide cannula, delivering a final volume of 0.5 μl of drug over 3 min, and leaving the cannula in position for an additional minute to allow for drug diffusion away from the injector tip. The internal-injector cannula protruded 1 mm beyond the guide cannula toward the LAH (Fig. 1 ). On the basis of the volume selected and the diffusion rate of microinjected substances (Routtenberg, 1972) together with preliminary studies performed in our laboratory with microinjected dyes (data not shown), the spread of drug beyond the LAH of animals with correctly verified cannula placements is limited. Importantly, although it is difficult to restrict the spread of drug to the LAH and limit diffusion dorsal of the injection site (i.e. to the medial dorsal AH), the sparse distribution of GABA receptors in the dorsal medial regions of the LAH would suggest that receptor agonism and antagonism effects were produced within the LAH. (Morin and Wood, 2001 ) and a representative photomicrograph of a coronal section of the Syrian hamster brain indicating the sites of central administration of muscimol into the LAH. The symbol '•' indicates an injection 'hit' within the LAH, whereas the symbol '□' indicates an injection 'miss' outside of the LAH target zone. Note in the photomicrograph (from the dorsal to ventral axis) the track of the guide cannula and injection needle (arrows). AH, anterior hypothalamus; F, fornix; LAH, lateral anterior hypothalamus; LH, lateral hypothalamus; MeA, medial amygdala; NC, nucleus circularis; son, supraoptic nucleus; SOX, optic chiasm, ot, optic tract.
Behavioral testing
After the microinjection, animals were returned to their home cage for 10 min before undergoing behavioral testing. Hamsters were tested for offensive aggression using the resident-intruder paradigm, a wellcharacterized and ethologically valid model of offensive aggression in Syrian hamsters (Lerwill and Makings, 1971; Floody and Pfaff, 1974) . Briefly, a novel intruder of similar size and weight was introduced into the home cage of the experimental animal (resident) and the resident was scored for general measures of offensive aggression (i.e. the frequency of attacks and bites) towards intruders, followed by a more detailed analysis of specific and targeted aggressive responses including frontal and rump/belly attacks, as previously described (Grimes et al., 2003; Wommack and Delville, 2003; Ricci et al., 2006) and flank marking, that is, a measure of social communication that is part of the larger ethogram of offensive aggression in hamsters (Lerwill and Makings, 1971; Floody and Pfaff, 1977) . An attack was scored each time the resident animal would pursue and then either (a) lunge toward and possibly (b) confine the intruder by upright and sideways threat; each was generally followed by a direct attempt to bite the intruder's dorsal rump or ventral target area(s). Latency to attack was defined as the period of time between the beginning of the behavioral test and the first attack the residents made toward an intruder. In the case of no attacks, latencies to attack were assigned the maximum latency (i.e. 600 s). Each aggression test lasted for 10 min and was videotaped and scored manually by two observers unaware of the hamsters' experimental treatment. Inter-rater reliability was set at 95%. No intruder was used for more than one behavioral test, and all subjects were tested during the first 4 h of the dark cycle under dim red illumination, to control for circadian influences on behavioral responding. In addition to aggressive behaviors, residents were tested for an array of social, comfort, and motor behaviors, to control for nonspecific effects of GABA agonists and antagonists. Social interest was measured by determining physical contact time, that is, the duration of time which experimental residents initiated and maintained contact with the intruder. Self-grooming by experimental residents during the 10-min agonistic encounter was used as a measure of comfort behavior, whereas changes in locomotor activity (i.e. line crosses) and escape attempts (i.e. wall climbing) were used to measure possible changes in motor activity due to GABA receptor agonism/ antagonism.
Experimental design
Syrian hamsters (P27) received daily subcutaneous injections of an AAS cocktail for 30 days of adolescence (P27-P56). One day following the last injection (P57), AAS-treated hamsters were randomly assigned to treatment groups (n ≥ 15/group, seven groups) and tested for offensive aggression following an injection into the LAH of saline (0 pmol/l) or one of three doses of the GABA A receptor agonist muscimol (0.01, 0.1, or 1.0 pmol/l) or the GABA A receptor antagonist bicuculline (0.04, 0.4, or 4.0 pmol/l). Muscimol and bicuculline were selected on the basis of their affinities for the GABA A receptor (muscimol; K i = 0.1 µmol/l, bicuculline; K i = 14.3 µmol/l), and the dose ranges were selected on the basis of previous effective doses in rats and mice (Earley and Leonard, 1977; Krsiak et al., 1981; Poshivalov, 1981; Puglisi-Allegra et al., 1981; Potegal et al., 1982; Haug et al., 1984; Clement et al., 1987; Chapouthier, 1996, 1998) .
Histology
To verify cannula placement, animals were anesthetized with isoflurane on the day following behavioral testing and transcardially perfused with 4% paraformaldehyde. Brains were removed, postfixed for 90 min in perfusion fixative, and cryoprotected overnight in 30% sucrose at 41°C. Brains were cut at 40 mm on a freezing microtome in serial, coronal sections and mounted on gelatin-coated slides. Sections were stained with cresyl violet, dehydrated through a series of alcohols, cleared with xylene, and coverslipped with Cytoseal (Stephens Scientific, Kalamazoo, Michigan, USA). Only animals with correctly placed cannula tips into the AH were included in the statistical analysis ( Fig. 1) .
Drugs
Testosterone cypionate, nandrolone decanoate, and boldenone undecylenate were purchased from Steraloids Inc. (Newport, Rhode Island, USA) and prepared in sesame oil. Muscimol and bicuculline were purchased from Sigma Aldrich (St Louis, Missouri, USA) and dissolved in 0.9% (w/v) normal saline.
Statistical analysis
To determine whether stereotaxic surgery altered aggression compared with surgically naïve controls, AAStreated animals injected with saline on the test day were collapsed across experiments and compared with surgically naïve AAS-treated hamsters using Student's t-test. For microinjection studies, behavioral measures were compared between treatment groups using one-way analysis of variance, followed by Fisher's protected least significant difference post-hoc test (two-tailed) when applicable. Aggression scores of animals with cannulae placed outside the AH were compared with AAStreated hamsters injected with saline using one-way analysis of variance. The α-level was set at 0.05 for all analyses.
Results
Histological verification
In this experiment, 65 animals with correct unilateral cannula placements in the LAH were included in the behavioral analysis (muscimol; 0.0 pmol/l: n = 13, 0.01 pmol/l: n = 8, 0.1 pmol/l: n = 8, 1.0 pmol/l: n = 8; bicuculline; 0.04 mmol/l: n = 10, 0.4 mmol/l: n = 9, 4.0 mmol/l: n = 9). Some animals were injected outside the LAH (muscimol; 0.0 pmol/l: n = 2, 0.01 pmol/l: n = 4, 0.1 pmol/l: n = 4, 1.0 pmol/l: n = 4; bicuculline; 0.04 mmol/ l: n = 2, 0.4 mmol/l: n = 3, 4.0 mmol/l: n = 3) with cannulae placed laterally in either the rostral or caudal direction to the LAH (Fig. 1 ). Treatment with muscimol or bicuculline outside the AH had no significant effect on adolescent AAS-induced aggression [t(12) = 0.42, NS].
γ-Aminobutyric acid effects on behavior γ-Aminobutyric acid effects on offensive aggression Microinjection of the GABA A receptor agonist muscimol into the LAH produced a significant overall effect on offensive aggression [F(3,35) = 4.66, P < 0.01] with an effective dose of 0.1 pmol/l. At this dose, muscimol treatment significantly increased composite aggression [t(19) = 3.85, P < 0.01], when compared with aggressive, adolescent AAS-treated hamsters injected with saline into the LAH. Specifically, infusion of muscimol into the LAH produced a two-fold increase in the frequency of aggressive behaviors during the 10-min test period ( Fig. 2a ). Lower (0.01 pmol/l) and higher (1.0 pmol/l) doses of muscimol, however, had no significant effect on composite aggression scores: 0.01 pmol/l [t(19) = 0.34, NS] and 1.0 pmol/l [t(19) = 1.38, NS]. In comparison, microinjection of the GABA A receptor antagonist bicuculline into the LAH of aggressive, adolescent AAStreated hamsters at all doses applied had no significant effect on offensive aggression [F(3,25) = 0.82, NS] compared with AAS-treated hamsters injected with saline into the LAH (Fig. 2b) .
The GABA A receptor agonist muscimol produced an overall effect on several components of the aggressive response of adolescent AAS-treated hamsters. In particular, muscimol significantly increased the frequency of attack behavior [F(3,35) = 5.11, P < 0.001] in AAS-treated animals, compared with hamsters injected with saline into the LAH, with the effective dose from ranging from 0.1 pmol/l [t(19) = 3.6, P < 0.001] to 1.0 pmol/l [t(19) = 2.21, P < 0.05]. In fact, infusion of these two doses of muscimol into the LAH of aggressive, adolescent AAS-treated animals produced a 2-2.5-fold increase in the frequency of attacks observed during the 10-min test (Fig. 3a) . No similar effects were observed when aggressive, adolescent AAS-treated animals were treated with lower (0.01 pmol/l) doses of muscimol [t(19) = 0.26, NS]. Similarly, microinjection of the GABA A receptor agonist muscimol into the LAH of aggressive, adolescent AAS-treated hamsters produced a trend towards an increase in the frequency of bites [F(3,35) = 2.18, P = 0.07] during the 10-min test period. In particular, compared with littermate controls injected with saline into the LAH, AAS-treated hamsters administered muscimol showed a significant increase in the frequency of bites during the test, specifically at an effective dose of 0.1 pmol/l [t(19) = 2.75, P < 0.01]. At this dose adolescent AAS-treated animals displayed a nearly three-fold increase in the frequency of bites observed during the 10-min test (Fig. 3b ). No similar effects were observed when aggressive, adolescent AAS-treated animals were treated with lower (0.01 pmol/l) or higher (1.0 pmol/l) doses of muscimol [t(19) = 0.26 and 1.13, respectively, NS].
A more detailed examination of the effects of muscimol on the aggressive phenotype showed that the GABA A receptor agonist produced a significant overall effect on select targeted offensive responses, namely belly/rear attacks [F(3,35) = 6.64, P < 0.001] and frontal attacks [F(3,35) = 3.79, P < 0.01]. In particular, similar to the effect observed for general attacks alone, adolescent AAS-treated animals administered muscimol significantly increased the frequency of attacks targeted to the belly/ rear region of intruders, compared with hamsters injected with saline into the LAH, with the effective dose ranging from 0.1 pmol/l [t(19) = 4.9, P < 0.001] to 1.0 pmol/l [t(19) = 2.84, P < 0.01]. Infusion of these doses of muscimol into the LAH of aggressive, adolescent AAStreated animals produced a 1.5-2-fold increase in the frequency of belly/rear attacks observed during the 10-min test (Fig. 4a ). No similar effects were observed when aggressive, adolescent AAS-treated animals were treated with lower (0.01 pmol/l) doses of muscimol [t(19) = 1.34, NS]. Interestingly, muscimol significantly decreased the frequency of frontal attacks in adolescent AAS-treated animals, compared with hamsters injected with saline into the LAH, with an effect only observed at the low (0.01 pmol/l) dose [t(19) = 2.85, P < 0.01]. Here adolescent AAS-treated animals showed a nearly five-fold decrease in the frequency of frontal attacks observed during the 10-min test (Fig. 4b) , reducing the frequency of frontal attacks to that of nonaggressive, sesame oil-treated control animals (dashed line in Fig. 4b ). No similar effects were observed when aggressive, adolescent AAS-treated animals were treated with higher (0.1 and 1.0 pmol/l) doses of muscimol [t(19) = 1.34 and 0.05, respectively, NS]. And lastly, microinjection of the GABA A receptor agonist muscimol into the LAH of aggressive, adolescent AAS-treated hamsters, at all doses applied, showed no significant overall effect on flank marking [F(3,35) = 1.28, NS] compared with AAS-treated hamsters injected with saline into the LAH (Table 1) . 
Discussion
Pharmacological manipulation of GABA neural signaling modulates aggression in various species and animal models (Christmas and Maxwell, 1970; Cole and Wolf, 1970; DiMascio, 1973; Earley and Leonard, 1977; Krsiak et al., 1981; Poshivalov, 1981; Puglisi-Allegra et al., 1981; Potegal et al., 1982; Haug et al., 1984; Depaulis and Vergnes, 1985; Rodgers and Waters, 1985; Clement et al., 1987; Weerts et al., 1993; Chapouthier, 1996, 1998; Stork et al., 2000) , particularly through alterations in GABA A receptor signaling (Jorge et al., 2002; Miczek et al., 2003; De Almeida et al., 2005) . Specifically, activation and blockade of GABA A receptor activity with muscimol and bicuculline, respectively, have been shown to modulate aggressive behavior (Puglisi-Allegra et al., 1981; Potegal et al., 1983; Hansen and Ferreira, 1986) . Together, these studies show a link between GABA A receptor activity and the control of aggressive behavior. However, no research to date has explored the effects of these GABAergic compounds on adolescent AASinduced offensive aggression. Moreover, the majority of previous studies applied 'systemic' drug delivery techniques and reported concomitant alterations in general behavioral activation. Thus, this study used local microinfusion techniques to determine whether GABA A receptor activity in the center of the neural circuit controlling aggression, the LAH, would effectively modulate adolescent AAS-induced offensive aggression. Our findings show a dose-dependent facilitation of adolescent AAS-induced aggressive responding by pharmacological agonism of GABA A receptors in the LAH, with the effective dose beginning at 0.1 pmol/l of muscimol. Conversely, pharmacological antagonism of LAH GABA A receptor activity had no significant effect on aggressive responding in adolescent AAS-treated animals. These findings are unique not only because they show specificity of the GABA A receptor agonist to alter adolescent AAS-induced offensive aggression, but also because they show a site-specific brain locus, where GABA A receptor signaling acts to alter aggressive responding in adolescent AAS-treated animals. These findings are in agreement with earlier studies showing the LAH to be a specific brain region modulating control of aggression (Melloni and Ricci, 2010) .
Adolescence marks a critical developmental period during which pharmacological treatment can produce differential behavioral responses compared with adulthood. For example, adolescent rats show an increase in responsiveness to catecholaminergic antagonists but decreased sensitivity to catecholaminergic agonists when compared with younger or older rats (Spear and Brake, 1983) . In the Syrian hamster, adolescent animals transition from juvenile displays of play fighting to the development of mature adult aggression behaviors (Wommack and Delville, 2003) . In particular, during peripubescent development hamsters change the focus of their attacks from the face and cheeks (i.e. frontal attacks) to the lower belly and rump regions (i.e. belly/ rear attacks) (Wommack and Delville, 2003) . This behavioral change is gradual from postnatal day 28 (when frontal attacks dominate the behavioral response) to postnatal day 70 (when belly/rear attacks dominate).
However, in the current study, our animals are tested for adolescent AAS-induced offensive aggression on postnatal day 57, that is, a time at which the behavioral response pattern comprises nearly equal parts frontal : belly/rear attacks (Wommack and Delville, 2003) . In our animal model of adolescent AAS-induced offensive aggression, the majority of AAS-treated adolescents target their offensive responses to the flank and rear regions of intruders Melloni, 2010a, 2010b; Ricci et al., 2013) , a hallmark characteristic of the adult aggressive phenotype (Wommack and Delville, 2003; Taravosh-Lahn and Delville, 2004) , although some frontal attack behavior is still observed. Thus AAStreated animals display the adult form of offensive aggression in the absence of social learning, indicating that the AAS treatment regimen circumvents the learning of mature fighting behavior. In the current study, the analysis of the effects of muscimol on individual types of aggressive acts revealed a dose-dependent facilitation of specific aggressive behaviors characterized as mature forms of aggression (Pellis and Pellis, 1988; Wommack and Delville, 2003) . Specifically, GABA A receptor agonism within the LAH increased the number of belly/rear attacks at the higher doses tested (i.e. 0.1 and 1.0 pmol/l), while decreasing the number of frontal attacks at the lower dose (i.e. 0.01 pmol/l). In fact, adolescent AAStreated hamsters administered 0.01 pmol/l muscimol into the LAH displayed a similar frequency of frontal attacks as nonaggressive, sesame oil-treated control animals (dashed line in Fig. 4b ). Together, these data suggest that enhanced GABA neural signaling within the LAH of aggressive, adolescent AAS-treated animals may function to simultaneously activate mature forms of offensive aggression and suppress juvenile play behaviors, promoting the display of more serious adult displays of aggression in AAS-treated animals. This notion is supported by our prior studies showing that adolescent AAStreated animals that display a mature and highly escalated AAS-induced aggressive phenotype have more GABAcontaining afferent terminals and neuronal somata within the AH/LAH (Grimes et al., 2003; Schwartzer et al., 2009) .
A more in-depth understanding of the development of the LAH GABA neural system and how it modulates aggression development, as well as the influence of adolescent AAS exposure on both neurobiological and behavioral development is thus warranted.
Most research examining the role of GABA in aggression has made use of systemically applied GABA receptor agonists and antagonists to measure changes in aggressive responding. However, given the ubiquitous distribution of GABA receptors and the role of GABA in sedation, systemic drug administration has significant potential to cause concomitant alterations in behavioral activation. Our findings serve as the first behavioral measure of direct GABA A receptor activation in an aggressionspecific locus of the adolescent AAS-treated brain, that is, the LAH. Interestingly, enhanced aggression in adolescent AAS-treated animals administered GABA A receptor agonists to the LAH was observed in the presence of slightly lower locomotor and grooming activity. Given the extremely high number of aggressive acts observed on the part of AAS-treated residents administered 0.1 pmol/l muscimol, the reduction in locomotion most likely reflects an increased number, and extended period(s), of rest between attack bouts, while a reduction in grooming is likely the result of the resident's focus on pursuing aggressive acts. This notion is supported by the fact that decreases in locomotion and grooming were only observed together and at the aggression-enhancing dose (i.e. 0.1 pmol/l) of muscimol administered to the LAH and that animals with cannulae placed rostral or caudal to the LAH were no more or less aggressive than AAStreated animals injected with saline into the LAH, nor did they show any significant changes in locomotion or grooming. These findings support the notion that GABA A receptor activation within the LAH further enhances aggressive responding in already aggressive, adolescent AAS-treated animals, implicating the LAH brain region as a central mediator of adolescent AASinduced offensive aggression. In contrast, these behavioral effects may be a direct effect of GABA A receptor activation. Systemic administration of allosteric GABA A receptor agonists has been shown to directly decrease grooming in rats (Barros et al., 1994; Nin et al., 2012) and locomotion in mice (Krsiak and Sulcova, 1990) , whereas injections of the GABA A receptor agonist muscimol into the raphe nucleus have been shown to increase locomotion (Shim et al., 2014) . Further research on the effects of GABA A receptor agonists on AAS-treated (and non-AAS) animals is warranted to better understand the effects of these compounds on hypothalamus-related behaviors. To this end, it is important to consider potential mechanisms within the hypothalamus whereby GABA neural signaling through GABA A receptors can impart aggressionenhancing effects in adolescent AAS-treated animals.
The GABA neural system is sensitive to androgens in a fashion consistent with the generation of the aggressive phenotype. For instance, in rats, GABA neurons are more active and the expression of glutamic acid decarboxylase 65 (GAD 65 ) (a biosynthetic enzyme for GABA localized within synaptic terminals) is higher in the male hypothalamus (Grattan and Selmanoff, 1993; Grattan et al., 1996a Grattan et al., , 1996b Searles et al., 2000) . Also, castration and androgen receptor blockade decreases hypothalamic GABA levels in rat brain (Grattan and Selmanoff, 1993 , 1994a , 1994b Grattan et al., 1996a Grattan et al., , 1996b Yoo et al., 2000) , which can be restored by testosterone Selmanoff, 1994a, 1994b) . Studies from our laboratory showed that adolescent AAS exposure increases GABAcontaining afferent terminals across the entire AH (Grimes et al., 2003) and GABA-containing neuronal somata within the LAH , suggesting that adolescent AAS exposure increases AH/LAH GABA activity, contributing to the adolescent AASinduced aggressive phenotype. Further, sex-specific and age-specific effects of androgens on GABA A receptor expression and function have been identified and AAS exposure has been shown to directly alter GABA A receptor expression and function in rats (Clark and Henderson, 2003; Henderson et al., 2006) , whereas in mice chronic AAS alters the expression of GABA A receptors, namely α1, 2, 4, 5 and γ2 subunits (Pibiri et al., 2006) . Recent studies from our laboratory show that aggressive, adolescent AAS-treated hamsters have fewer GABA Aα1 receptors in the LAH compared with controls . Interestingly, this reduction is identical to the adolescent AAS-induced decrease in 5HT afferent innervation we observed in several prior studies Melloni, 2002, 2006) , leading us to hypothesize that GABA Aα1 receptors are located on 5HTcontaining presynaptic terminals in the LAH, and that the decrease in GABA Aα1 receptors in the LAH of adolescent AAS-treated animals is representative of the reduction in 5HT afferent innervation to the LAH during adolescent AAS exposure (Fig. 5) . It is possible that adolescent AAS-induced increases in GABA-containing neurons and afferent terminals in the LAH increase the inhibitory effect of GABA on GABA Aα1 receptors located on the remaining 5HT neural afferents in the LAH (Fig. 5b ). There is evidence that 5HT activity within the LAH normally functions to inhibit offensive aggression by suppressing the activity of AVP neurons in the LAH (Ferris et al., 1997; Melloni and Ricci, 2010) . From a . The − AAS model shows the hypothetical interaction between the 5HT, AVP, and GABA neural systems in the LAH. In the model, 5HT release within the LAH normally functions to inhibit offensive aggression by suppressing (− ) the activity of AH AVP neurons. Upstream of this modulation, the release of 5HT is under the inhibitory influence of GABA, acting through GABA Aα1 receptors located on 5HT afferents in the LAH. Under normal conditions (− AAS), there is insufficient GABA production, afferent innervation and release (Ø) within the LAH to inhibit the release of 5HT from the dense array of 5HT afferents that innervate the LAH brain region (shown as grey fibers). Because of the strong inhibitory (− ) influence of 5HT, AH AVP neurons facilitating aggression are inactive and animals are nonaggressive. Conversely, adolescent AAS exposure (+ AAS) increases GABA production, afferent innervation and release into the LAH, while suppressing the development of 5HT afferent fibers to the LAH. As a result, GABA, acting through GABA Aα1 receptors, functions to inhibit (− ) the remaining 5HT afferents in the LAH, effectively suppressing the release of 5HT. Under this condition, there is insufficient 5HT release (Ø) within the LAH to suppress the activity of AH AVP neurons facilitating aggression and animals display a highly aggressive behavioral phenotype. AAS, anabolic/androgenic steroids; AH, anterior hypothalamus; AVP, arginine vasopressin; GABA, γ-aminobutyric acid; 5HT, serotonin; LAH, lateroanterior hypothalamus.
Adolescent AAS, GABA, and aggression Morrison et al. 681 functional standpoint, an AAS-induced increase in GABAergic inhibition of the remaining 5HT afferent terminals in the LAH would serve to disinhibit downstream AVP neurons, facilitating offensive aggression in adolescent AAS-treated animals. Moreover, further activation of the remaining GABA Aα1 receptors by muscimol should enhance the suppression of 5HT release from the remainder of the 5HT afferent fibers, further augmenting the aggressive phenotype in adolescent AAS-treated animals. Conversely, inhibition of GABA Aα1 receptors by bicuculline should block the GABA-induced suppression of 5HT release from remaining 5HT afferent fibers within the LAH, potentially suppressing the aggressive phenotype. However, we believe this does not occur because of the significant AAS-induced reduction in 5HT afferent innervation to the LAH; therefore there is no longer sufficient 5HT within the LAH to suppress the downstream activity of AH AVP neurons facilitating aggression. Both of these circumstances are consistent with the behavioral findings reported in this study. These patterns of GABA activity would support the notion that the role of GABA in aggression is dependent upon the nature and extent of its interaction with other neural systems modulating this behavior, and offers a neural mechanism in support of the findings that GABA facilitates aggression in adolescent AAS-treated animals. This hypothesis is currently under investigation in our laboratory. In summary, the previous histological reports of increased GABA-containing afferent terminals and neurons in the LAH of adolescent AAS-treated hamsters, coupled with the current findings that GABA agonists delivered to the LAH facilitate adolescent AAS-induced offensive aggression, implicate the LAH as an important site of convergence where adolescent AAS exposure increases GABA neural development and activity to elevate aggressive responding.
